InjectionCritical Care Injection Infusion

MOLNUPIRAVIR

Molnupiravir · Nucleoside analogue antiviral

InjectionCritical Care Injection Infusion

MOLNUPIRAVIRProspero Healthcare

Molnupiravir is presented as an antiviral preparation and belongs to the class of nucleoside analogue antiviral. Its standard indications include cOVID-19 in selected adults, as determined by a prescribing clinician.

Uses

COVID-19 in selected adults

Enquire about this product

Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.

01Specification

Product details

Composition: Molnupiravir
Available strengthsIndicative: 200 mg
Dosage form: Injection
Therapeutic category: Critical Care Injection Infusion
Therapeutic class: Nucleoside analogue antiviral
Packing: Vial or ampoule, single unit or tray pack
Storage: Store below 25 °C, protected from light. Do not freeze.

02Related

From the same category

View the category

Injection
NIMODIPINE
NIMODIPINEInjection
Injection
Ranitidine Injection
Ranitidine InjectionInjection
Injection
VITAMIN K1 INJECTION
VITAMIN K1 INJECTIONInjection
Injection
CEREBROPROTEIN
CEREBROPROTEINInjection
Injection
ERTAPENEM
ERTAPENEMInjection
Injection
LEVOCARNITINE INJECTION
LEVOCARNITINE INJECTIONInjection